InvestorsHub Logo
Followers 42
Posts 8477
Boards Moderated 2
Alias Born 11/14/2019

Re: None

Saturday, 09/24/2022 6:40:39 PM

Saturday, September 24, 2022 6:40:39 PM

Post# of 22
VALUE OF 3CL PROTEASE INHIBITOR SUPPLEMENTATION 1 The Value of 3CL Protease Inhibitor Supplementation in Long Haul Syndrome Patients?

" Thus, based upon the research available to date, there is a strong indication that introducing a regimen of supplementation with a 3CL protease inhibitor early in the symptomatic phase increases the chances of resolving COVID-19 symptoms.
Additional research is needed to better understand the correlation of outcome with
early intervention."
" Over 80% of all respondents found improvement in both COVID and LHS symptoms after taking Tollovid. Results are significant and demonstrate a self-reported benefit to using the supplement for a 5-day course."
" In fact, the majority of LHS patients report that food supplementation is their primary mode to achieve symptom relief. In this publication, we report data from over 100 Acute COVID and LHS patients on the potential benefits of Tollovid, a 3CL protease inhibitor cleanse supplement.
Based upon this analysis, further investigation is warranted in a controlled, prospective clinical trial setting."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.